Eli Lilly Confirms 'Superior Weight Loss' Of Its Next-Generation Obesity Drug - Investor's Business Daily

Patients taking retatrutide, lost 16.8% of their body weight over 40 weeks.

You are being redirected to the original discussion. Please continue if you want to read the full post.

Continue to original article